TG Therapeutics, Inc. has announced a conference call scheduled for May 5, 2025, at 8:30 AM ET to discuss its first quarter financial results and provide a business outlook for the remainder of 2025.

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Tuesday August 6, 2024 at 8:30 AM ET to discuss results for the ...

Gender Odyssey, Seattle’s annual transgender conference, is in full swing with thousands of therapists, families, and advocates coming together in what is predicted to be the largest of the yearly ...

A group of more than a dozen Republican lawmakers is urging a collegiate athletic conference to ban transgender women from competition after it was reported that a trans student competed on the ...

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the ...

Republican leaders from Congress expressed "serious concern" with the Mountain West Conference about transgender women participating in women's sports. Thirteen officials signed a letter to Mountain ...

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, November 3, 2025, at 8:30 AM ET to discuss results for ...